应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06160 百济神州
交易中 07-03 13:33:53
87.450
+1.750
+2.04%
最高
87.900
最低
85.950
成交量
37.74万
今开
86.000
昨收
85.700
日振幅
2.28%
总市值
1,202亿
流通市值
1,202亿
总股本
13.75亿
成交额
3,285万
换手率
0.03%
流通股本
13.75亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
百济神州(688235)7月1日主力资金净买入844.62万元
证券之星 · 07-02 08:26
百济神州(688235)7月1日主力资金净买入844.62万元
百济神州(06160)根据股份计划发行约73.63万股
智通财经网 · 07-02 08:22
百济神州(06160)根据股份计划发行约73.63万股
百济神州下跌2.19%,报142.39美元/股
金融界 · 06-28
百济神州下跌2.19%,报142.39美元/股
坚守研发全球化策略 百济神州迎来收获季
每经网 · 06-28
坚守研发全球化策略 百济神州迎来收获季
百济神州获融资买入0.13亿元,近三日累计买入0.27亿元
金融界 · 06-28
百济神州获融资买入0.13亿元,近三日累计买入0.27亿元
百济神州(688235)6月27日主力资金净买入221.91万元
证券之星 · 06-28
百济神州(688235)6月27日主力资金净买入221.91万元
百济神州(06160)下跌5.04%,报85.8元/股
金融界 · 06-27
百济神州(06160)下跌5.04%,报85.8元/股
BTK抑制剂“后浪”奔涌!AZ、礼来持续发力,百济神州遭遇夹击?
医药经济报 · 06-26
BTK抑制剂“后浪”奔涌!AZ、礼来持续发力,百济神州遭遇夹击?
百济神州下跌5.04%,报151.13美元/股
金融界 · 06-26
百济神州下跌5.04%,报151.13美元/股
销售费用居高难下 、研发费用原地踏步,孙飘扬治下的恒瑞医药会被百济神州超越吗?
博望财经 · 06-25
销售费用居高难下 、研发费用原地踏步,孙飘扬治下的恒瑞医药会被百济神州超越吗?
百济神州(BGNE)涨超2% 因受限制股份单位获归属发行521.3万股
金吾财讯 · 06-24
百济神州(BGNE)涨超2% 因受限制股份单位获归属发行521.3万股
百济神州因受限制股份单位获归属而发行合计521.3万股
新浪港股 · 06-24
百济神州因受限制股份单位获归属而发行合计521.3万股
百济神州(06160)因受限制股份单位获归属而发行合计521.3万股
智通财经 · 06-24
百济神州(06160)因受限制股份单位获归属而发行合计521.3万股
百济神州(06160.HK)因受限制股份单位获归属发行521.3万股
格隆汇资讯 · 06-24
百济神州(06160.HK)因受限制股份单位获归属发行521.3万股
百济神州6月19日转融通出借成交46100股
金融界 · 06-20
百济神州6月19日转融通出借成交46100股
百济神州(688235)6月18日主力资金净买入329.62万元
证券之星 · 06-19
百济神州(688235)6月18日主力资金净买入329.62万元
百济神州(06160):股权计划下发行约168.67万股股份
和讯网 · 06-18
百济神州(06160):股权计划下发行约168.67万股股份
北向资金6月17日净买入百济神州-U9.81万股 连续3日增持
自选股智能写手 · 06-18
北向资金6月17日净买入百济神州-U9.81万股 连续3日增持
百济神州因受限制股份单位获归属而发行约168.67万股股份
新浪港股 · 06-18
百济神州因受限制股份单位获归属而发行约168.67万股股份
百济神州(06160)因受限制股份单位获归属而发行约168.67万股股份
智通财经 · 06-18
百济神州(06160)因受限制股份单位获归属而发行约168.67万股股份
公司概况
公司名称:
百济神州
所属市场:
SEHK
上市日期:
--
主营业务:
百济神州有限公司是一家主要从事生物制药业务的公司。该公司主要从事用于治疗癌症的创新分子靶向及免疫肿瘤药物的研发,生产和销售业务。该公司的主要产品包括Zanubrutinib(BGB-3111),Tislelizumab(BGB-A317)和Pamiparib(BGB-290)等。
发行价格:
--
{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":87.45,"timestamp":1719984811134,"preClose":85.7,"halted":0,"volume":377425,"delay":0,"floatShares":1374796432,"shares":1374796432,"eps":-5.0763803,"marketStatus":"交易中","marketStatusCode":2,"change":1.75,"latestTime":"07-03 13:33:53","open":86,"high":87.9,"low":85.95,"amount":32847150,"amplitude":0.022754,"askPrice":87.5,"askSize":1400,"bidPrice":87.45,"bidSize":1700,"shortable":3,"etf":0,"ttmEps":-4.515145596174731,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1719994200000},"adr":0,"listingDate":1533657600000,"adjPreClose":85.7,"openAndCloseTimeList":[[1719970200000,1719979200000],[1719982800000,1719993600000]],"volumeRatio":0.522069,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":116.68,"timestamp":1719984831000,"preClose":113.84,"halted":0,"volume":762849,"delay":0,"premium":"-29.88"}},"requestUrl":"/m/hq/s/06160/wiki","defaultTab":"wiki","newsList":[{"id":"2448632920","title":"百济神州(688235)7月1日主力资金净买入844.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448632920","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448632920?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:26","pubTimestamp":1719879970,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月1日收盘,百济神州报收于113.6元,下跌1.93%,换手率1.12%,成交量1.29万手,成交额1.47亿元。近5日资金流向一览见下表:百济神州融资融券信息显示,融资方面,当日融资买入695.09万元,融资偿还660.09万元,融资净买入35.0万元,连续3日净买入累计928.15万元。百济神州主营业务:研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1500","BK1583","06160","LU2328871848.SGD","BK1588","BK1161","LU1969619763.USD","BK0239","688235","LU0588546209.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2448927113","title":"百济神州(06160)根据股份计划发行约73.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448927113","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448927113?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:22","pubTimestamp":1719879749,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)发布公告,于2024年6月30日,该公司就根据股份计划授予参与人(发行人的董事除外)的股份奖励或期权而合计发行约73.63万股。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK4504","LU1969619763.USD","BK4139","BK4505","06160","BK4526","BK1500","BK4535","BGNE","BK1588","BK4585","688235","BK1161","BK1583","BK4548","LU2328871848.SGD","LU0588546209.SGD","BK4588","LU0307460666.USD"],"gpt_icon":0},{"id":"2446681344","title":"百济神州下跌2.19%,报142.39美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446681344","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446681344?lang=zh_cn&edition=full","pubTime":"2024-06-28 22:43","pubTimestamp":1719585795,"startTime":"0","endTime":"0","summary":"6月28日,百济神州(BGNE)盘中下跌2.19%,截至22:43,报142.39美元/股,成交710.49万美元。财务数据显示,截至2024年03月31日,百济神州收入总额7.52亿美元,同比增长67.85%;归母净利润-2.51亿美元,同比增长27.92%。大事提醒:8月7日,百济神州将披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/28224341274942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BGNE","BK4585","BK4588","BK4139","BK4504","BK4526","BK1588","BK4505","BK1500","LU0307460666.USD","BK0239","LU0588546209.SGD","06160","LU2328871848.SGD","BK1583","BK4548","LU1969619763.USD","BK1161","BK4535","688235"],"gpt_icon":0},{"id":"2446164525","title":"坚守研发全球化策略 百济神州迎来收获季","url":"https://stock-news.laohu8.com/highlight/detail?id=2446164525","media":"每经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446164525?lang=zh_cn&edition=full","pubTime":"2024-06-28 14:45","pubTimestamp":1719557129,"startTime":"0","endTime":"0","summary":"继2023年将泽布替尼打造成为公司首款自研“重磅炸弹”药物后,百济神州的全球化征途再进一程。得益于全球收入的大幅增长,按抗肿瘤药物总销售额计算,百济神州现已跻身全球肿瘤治疗创新公司前15强。目前,百悦泽已经在全球70个市场获批。对此,百济神州采取的研发策略是差异化。其2023年A股年报显示,百济神州的境内和境外收入分别为78亿元和96.22亿元,同比增长率分别为37.46%和147.27%。在2019年至2023年期间,百济神州还大力","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281445429f6f1e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281445429f6f1e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","BGNE","BK0239"],"gpt_icon":0},{"id":"2446518385","title":"百济神州获融资买入0.13亿元,近三日累计买入0.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446518385","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446518385?lang=zh_cn&edition=full","pubTime":"2024-06-28 08:21","pubTimestamp":1719534112,"startTime":"0","endTime":"0","summary":"6月27日,沪深两融数据显示,百济神州获融资买入额0.13亿元,居两市第370位,当日融资偿还额0.06亿元,净买入656.04万元。最近三个交易日,25日-27日,百济神州分别获融资买入0.07亿元、0.08亿元、0.13亿元。融券方面,当日融券卖出2.43万股,净卖出1.43万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062808220395dff738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062808220395dff738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","688235","BGNE","BK0239"],"gpt_icon":0},{"id":"2446651855","title":"百济神州(688235)6月27日主力资金净买入221.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446651855","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446651855?lang=zh_cn&edition=full","pubTime":"2024-06-28 08:20","pubTimestamp":1719534041,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月27日收盘,百济神州报收于116.16元,下跌4.27%,换手率1.35%,成交量1.56万手,成交额1.83亿元。近5日资金流向一览见下表:百济神州融资融券信息显示,融资方面,当日融资买入1261.29万元,融资偿还605.26万元,融资净买入656.04万元,连续3日净买入累计888.01万元。百济神州主营业务:研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800013508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","BK1583","LU0588546209.SGD","BK0239","BK1161","LU2328871848.SGD","LU1969619763.USD","LU0307460666.USD","BK1588","688235","BK1500"],"gpt_icon":0},{"id":"2446377075","title":"百济神州(06160)下跌5.04%,报85.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446377075","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446377075?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:28","pubTimestamp":1719466083,"startTime":"0","endTime":"0","summary":"6月27日,百济神州(06160)盘中下跌5.04%,截至13:28,报85.8元/股,成交5076.32万元。百济神州有限公司是一家专注于开发和商业化用于治疗癌症的创新型分子靶向和肿瘤免疫治疗药物的生物技术公司。公司拥有包括六种内部开发的临床阶段候选药物和五种获得授权许可的药物在内的广泛产品组合,以及超过1300名员工的全球团队。截至2024年一季报,百济神州营业总收入53.33亿元、净利润-17.82亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/27132841231327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1500","BK4535","BK4504","LU1969619763.USD","BK4526","06160","BK4505","LU0588546209.SGD","BK1583","BK4139","LU0307460666.USD","688235","LU2328871848.SGD","BK0239","BK4585","BGNE","BK1161","BK4588","BK1588","BK4548"],"gpt_icon":0},{"id":"2446367863","title":"BTK抑制剂“后浪”奔涌!AZ、礼来持续发力,百济神州遭遇夹击?","url":"https://stock-news.laohu8.com/highlight/detail?id=2446367863","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446367863?lang=zh_cn&edition=full","pubTime":"2024-06-26 20:15","pubTimestamp":1719404134,"startTime":"0","endTime":"0","summary":"作为近年来高速增长的细分赛道,BTK抑制剂市场加速涌入新的搅局者。获批上市的6款BTK抑制剂在业内看来,BTK抑制剂研发火热的同时,新的市场格局也悄然发生变化。此前,国内BTK抑制剂市场主要由伊布替尼、泽布替尼和奥布替尼等药物主导,形成了“三足鼎立”的局面。在2023年报中,百济神州的BTK抑制剂泽布替尼全年销售额突破13亿美元,同比增长129%。不过,随着新一代BTK抑制剂阿卡替尼、泽布替尼、奥","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262017119f67bf6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262017119f67bf6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGNE","BK1500","LLY","688235","BK1583","LU0307460666.USD","LU1969619763.USD","06160","BK1161","LU2328871848.SGD","LU0588546209.SGD","BK1588"],"gpt_icon":0},{"id":"2446822313","title":"百济神州下跌5.04%,报151.13美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446822313","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446822313?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:29","pubTimestamp":1719336595,"startTime":"0","endTime":"0","summary":"6月26日,百济神州(BGNE)盘中下跌5.04%,截至01:29,报151.13美元/股,成交2130.59万美元。财务数据显示,截至2024年03月31日,百济神州收入总额7.52亿美元,同比增长67.85%;归母净利润-2.51亿美元,同比增长27.92%。大事提醒:8月7日,百济神州将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/26012941191860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1969619763.USD","LU0588546209.SGD","BK4588","BK4585","BK4548","06160","BK1588","BK0239","BK4139","BK1161","LU0307460666.USD","LU2328871848.SGD","688235","BK4535","BK4505","BK1583","BK1500","BGNE","BK4504","BK4526"],"gpt_icon":0},{"id":"2446230832","title":"销售费用居高难下 、研发费用原地踏步,孙飘扬治下的恒瑞医药会被百济神州超越吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2446230832","media":"博望财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446230832?lang=zh_cn&edition=full","pubTime":"2024-06-25 08:56","pubTimestamp":1719276960,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 近日,美国《制药经理人》杂志发布了2024年全球制药企业TOP50榜单,恒瑞医药再次上榜。自2019年以来,公司已连续六年进入该榜单。今年榜单披露的数据显示,恒瑞医药2023年研发投入仍然位居上榜中国药企首位。但恒瑞在狂烧钱的创新药领域并不具备身位优势。这一次,孙飘扬还能妙手回春吗?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-06-25/doc-inazxaqs1698510.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-06-25/doc-inazxaqs1698510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06160","BK0196","BK0239","BK1583","BK4585","688235","BK4526","BK4548","LU2328871848.SGD","BK0012","BK4588","LU1328615791.USD","LU0588546209.SGD","BK0060","LU0307460666.USD","LU1969619763.USD","BGNE","LU0405327494.USD","600276","LU0405327148.USD","BK0183","LU2148510915.USD","LU1064130708.USD","BK4504","BK1161","LU1064131003.USD","BK4535","BK4505","BK0028","BK1588","BK1500","BK4139","BK0188"],"gpt_icon":0},{"id":"2445211070","title":"百济神州(BGNE)涨超2% 因受限制股份单位获归属发行521.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445211070","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445211070?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:26","pubTimestamp":1719239177,"startTime":"0","endTime":"0","summary":"金吾财讯 | 百济神州(BGNE)涨超2%,报159.9美元。消息面上,公司发布公告,2024年6月22日,因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行510.87万股普通股。同日,因根据股权计划授出予公司董事的受限制股份单位获归属而发行10.44万股普通股。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGU1YzNhMmY0MDcxNDc2NDI4MDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGU1YzNhMmY0MDcxNDc2NDI4MDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277096","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","06160","688235","BK1588","BK4588","BK1500","BK4526","BK4585","LU1969619763.USD","BK4504","BK4139","BK0239","BK1161","BGNE","LU0307460666.USD","LU2328871848.SGD","BK4505","BK1583","BK4548","BK4535"],"gpt_icon":0},{"id":"2445982720","title":"百济神州因受限制股份单位获归属而发行合计521.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445982720","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445982720?lang=zh_cn&edition=full","pubTime":"2024-06-24 08:51","pubTimestamp":1719190308,"startTime":"0","endTime":"0","summary":"百济神州(06160)发布公告,于2024年6月22日因根据股权计划授出的受限制股份单位获归属而发行普通股合计521.3万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-24/doc-inazuxrs2445416.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-24/doc-inazuxrs2445416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["LU0307460666.USD","BK1588","LU0588546209.SGD","BK1500","BK1583","LU1969619763.USD","06160","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2445306062","title":"百济神州(06160)因受限制股份单位获归属而发行合计521.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445306062","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445306062?lang=zh_cn&edition=full","pubTime":"2024-06-24 08:15","pubTimestamp":1719188120,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)发布公告,于2024年6月22日因根据股权计划授出的受限制股份单位获归属而发行普通股合计521.3万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","06160","688235","BK1588","BK4588","BK1500","BK4526","BK4585","LU1969619763.USD","BK4504","BK4139","BK0239","BK1161","BGNE","LU0307460666.USD","LU2328871848.SGD","BK4505","BK1583","BK4548","BK4535"],"gpt_icon":0},{"id":"2445060052","title":"百济神州(06160.HK)因受限制股份单位获归属发行521.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445060052","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445060052?lang=zh_cn&edition=full","pubTime":"2024-06-24 08:07","pubTimestamp":1719187652,"startTime":"0","endTime":"0","summary":"格隆汇6月24日丨百济神州(06160.HK)发布公告,2024年6月22日,因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行510.87万股普通股。同日,因根据股权计划授出予公司董事的受限制股份单位获归属而发行10.44万股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062408074595d052a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062408074595d052a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU0588546209.SGD","LU0307460666.USD","BK1588","LU2328871848.SGD","LU1969619763.USD","06160","BK1583","BK1161"],"gpt_icon":0},{"id":"2444128070","title":"百济神州6月19日转融通出借成交46100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2444128070","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444128070?lang=zh_cn&edition=full","pubTime":"2024-06-20 08:44","pubTimestamp":1718844282,"startTime":"0","endTime":"0","summary":"根据上交所网站显示,6月19日,百济神州转融通出借成交46100股,其中期限为14天的成交45000股,期限为28天的成交1100股。据了解,转融通是指证券金融公司将自有或者依法筹集的资金和证券出借给证券公司,以供其办理融资融券业务的经营活动。上交所接受借入人借入申报的时间为每个交易日 9:15 至 11:30、13:00 至 15:10。公开资料显示,百济神州法人代表为None,公司注册资本13.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406200844539f504e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406200844539f504e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","BGNE","BK1583","BK1588","LU0307460666.USD","688235","LU1969619763.USD","LU2328871848.SGD","BK1500","BK1161","LU0588546209.SGD"],"gpt_icon":0},{"id":"2444493587","title":"百济神州(688235)6月18日主力资金净买入329.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444493587","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444493587?lang=zh_cn&edition=full","pubTime":"2024-06-19 08:21","pubTimestamp":1718756499,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月18日收盘,百济神州报收于126.11元,下跌1.4%,换手率0.91%,成交量1.05万手,成交额1.33亿元。近5日资金流向一览见下表:百济神州融资融券信息显示,融资方面,当日融资买入1286.74万元,融资偿还922.05万元,融资净买入364.7万元。百济神州主营业务:研究、开发、生产以及商业化创新型药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900013388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","LU1969619763.USD","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","BK1583","BK1500","BK0239","BK1588","06160","BK1161"],"gpt_icon":0},{"id":"2444412854","title":"百济神州(06160):股权计划下发行约168.67万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2444412854","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444412854?lang=zh_cn&edition=full","pubTime":"2024-06-18 09:53","pubTimestamp":1718675617,"startTime":"0","endTime":"0","summary":"快讯摘要百济神州因股权计划授出的受限制股份单位归属,于2024年6月17日发行约168.67万股股份。快讯正文【百济神州因股权计划授出受限制股份单位获归属发行约168.67万股】百济神州于2024年6月17日宣布,由于股权计划下的受限制股份单位达到归属条件,公司发行了约168.67万股股份,此次发行不包括公司董事。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061809543195bb8eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061809543195bb8eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1500","LU2328871848.SGD","BK1583","LU0588546209.SGD","LU0307460666.USD","BK1588","BK1161","06160"],"gpt_icon":0},{"id":"2444407431","title":"北向资金6月17日净买入百济神州-U9.81万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2444407431","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444407431?lang=zh_cn&edition=full","pubTime":"2024-06-18 09:30","pubTimestamp":1718674237,"startTime":"0","endTime":"0","summary":"6月17日, 北向资金增持百济神州-U9.81万股,连续3日增持。截止当日收盘,沪股通共持有百济神州-U570.98万股,占流通股4.96%。沪股通增持金额前五个股分别为赛力斯、国电南瑞、中信银行、中远海控、山西汾酒。百济神州-U近5个交易日上涨3.05%,沪股通累计增持16.54万股;近20个交易日下跌4.10%,沪股通累计增持22.32万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061809361295bb7d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061809361295bb7d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK0239","BGNE","06160"],"gpt_icon":0},{"id":"2444144312","title":"百济神州因受限制股份单位获归属而发行约168.67万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2444144312","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444144312?lang=zh_cn&edition=full","pubTime":"2024-06-18 08:48","pubTimestamp":1718671691,"startTime":"0","endTime":"0","summary":"百济神州(06160)公布,2024年6月17日,因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约168.67万股股份。\n\nMACD金叉信号形成,这些股涨势不错!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-18/doc-inazcets3962886.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-18/doc-inazcets3962886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["06160","BK1583","LU0588546209.SGD","BK1161","LU2328871848.SGD","LU1969619763.USD","LU0307460666.USD","BK1588","BK1500"],"gpt_icon":0},{"id":"2444146815","title":"百济神州(06160)因受限制股份单位获归属而发行约168.67万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2444146815","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444146815?lang=zh_cn&edition=full","pubTime":"2024-06-18 07:47","pubTimestamp":1718668029,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)公布,2024年6月17日,因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约168.67万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1136532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","06160","BK4535","BK1500","BK4139","BK1588","BK4588","BK0239","BK4504","BK1583","LU1969619763.USD","BK4548","BK4505","BK1161","688235","BGNE","BK4526","LU2328871848.SGD","BK4585","LU0307460666.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beigene.com","stockEarnings":[{"period":"1week","weight":-0.0898},{"period":"1month","weight":-0.0322},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.2065},{"period":"1year","weight":-0.2079},{"period":"ytd","weight":-0.2216}],"compareEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0172},{"period":"3month","weight":0.0624},{"period":"6month","weight":0.0675},{"period":"1year","weight":-0.0796},{"period":"ytd","weight":0.0423}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百济神州有限公司是一家主要从事生物制药业务的公司。该公司主要从事用于治疗癌症的创新分子靶向及免疫肿瘤药物的研发,生产和销售业务。该公司的主要产品包括Zanubrutinib(BGB-3111),Tislelizumab(BGB-A317)和Pamiparib(BGB-290)等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03281},{"month":2,"riseRate":0.5,"avgChangeRate":0.020001},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.060772},{"month":4,"riseRate":0.5,"avgChangeRate":0.051983},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.053583},{"month":6,"riseRate":0.5,"avgChangeRate":0.011188},{"month":7,"riseRate":0.666667,"avgChangeRate":0.051235},{"month":8,"riseRate":0.8,"avgChangeRate":0.040871},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.025087},{"month":10,"riseRate":0.666667,"avgChangeRate":0.006083},{"month":11,"riseRate":0.5,"avgChangeRate":0.130955},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.054912}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}